Yuichi Saito

Dr. Yuichi Saito

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Cardiology
Verified
Journal Article
Closed access
YSYuichi Saito
Yuichi Saito
ATAtsushi Tanaka
Atsushi Tanaka
KNKoichi Node
Koichi Node
YKYoshio Kobayashi
Yoshio Kobayashi

23 July 2022 in Journal of Cardiology
Verified
Journal Article
Closed access
YSYuichi Saito
Yuichi Saito
KOKazuma Oyama
Kazuma Oyama
KTKenichi Tsujita
Kenichi Tsujita
SYSatoshi Yasuda
Satoshi Yasuda
YKYoshio Kobayashi
Yoshio Kobayashi

30 September 2019 in Cardiovascular Intervention and Therapeutics
Verified
Journal Article
Closed access
PDF file
YSYuichi Saito
Yuichi Saito
YKYoshio Kobayashi
Yoshio Kobayashi
KFKenichi Fujii
Kenichi Fujii
SSShinjo Sonoda
Shinjo Sonoda
KTKenichi Tsujita
Kenichi Tsujita
JHJunko Honye
Junko Honye

12 November 2021 in Cardiovascular Intervention and Therapeutics
Verified
Journal Article
Open access
PDF file
YSYuichi Saito
Yuichi Saito
YKYoshio Kobayashi
Yoshio Kobayashi
KFKenichi Fujii
Kenichi Fujii
SSShinjo Sonoda
Shinjo Sonoda
KTKenichi Tsujita
Kenichi Tsujita
JHJunko Honye
Junko Honye
Intravascular ultrasound (IVUS) provides precise anatomic information in coronary arteries including quantitative measurements and morphological assessment. To standardize the IVUS analysis in the current era, this updated expert consensus document summarizes the methods of measurements and assessment of IVUS images and the clinical evidence of IVUS use in percutaneous coronary intervention.

5 September 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
YSYuichi Saito
Yuichi Saito
KTKAZUYA TATEISHI
KAZUYA TATEISHI
KTKoichi Toda
Koichi Toda
GMGoro Matsumiya
Goro Matsumiya
YKYoshio Kobayashi
Yoshio Kobayashi
FIfor the J‐PVAD registry study investigators
for the J‐PVAD registry study investigators
Background: In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. However, data are limited on complications and outcomes of Impella treatment in patients with CS with and without AMI. Methods and Results: Using nationwide prospective registry data in Japan, we included a total of 2047 patients with CS in whom the Impella devices were successfully placed between February 2020 and December 2021. Patients were divided into 2 groups according to the primary indication for the Impella use: AMI versus non‐AMI. The primary end point was a composite of in‐hospital all‐cause death and major complications. Of the 2047 patients, the Impella was indicated for AMI in 1337 (65.3%). In the group without AMI, myocarditis was the leading cause of CS. Patients with AMI‐CS were older and more likely to have cardiovascular risk factors than those with non‐AMI‐CS. The rates of in‐hospital mortality (46.0% versus 43.9%, P =0.38) and major complications (35.2% versus 34.7%, P =0.85) were similar between the 2 groups. Overall, multivariable analysis identified older age, higher body mass index, previous transient ischemic attack or stroke, out‐of‐hospital cardiac arrest, and the Impella 5.0 as factors significantly associated with the primary end point. Conclusions: The use of Impella in patients with and without AMI was related to similar clinical outcomes with high mortality and complication rates. Further studies are needed to identify patients who may benefit from the Impella devices in CS. Registration: URL: https://www.umin.ac.jp/english . Identifier: UMIN000033603.

1 September 2023 in Cardiovascular Intervention and Therapeutics
Verified
Journal Article
Open access
PDF file
YSYuichi Saito
Yuichi Saito
YKYoshio Kobayashi
Yoshio Kobayashi
KFKenichi Fujii
Kenichi Fujii
SSShinjo Sonoda
Shinjo Sonoda
KTKenichi Tsujita
Kenichi Tsujita
JHJunko Honye
Junko Honye
Intravascular ultrasound (IVUS) provides precise anatomic information in coronary arteries including quantitative measurements and morphological assessment. To standardize the IVUS analysis in the current era, this updated expert consensus document summarizes the methods of measurements and assessment of IVUS images and the clinical evidence of IVUS use in percutaneous coronary intervention.